Company · Birmingham
Nonacus Limited
Research and experimental development on biotechnology
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Nonacus Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 2
- Kay Garnett 2019-2023 View profile
- Christopher David Sale 2016-2019 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
Public contracts won
2 contracts · £203,154 totalFrom Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.
-
NEXT GENERATION SEQUENCING PANEL FOR FAMILIAL HYPERCHOLESTEROLEMIA AND WHOLE EXOME SEQUENCING LIBRARY PREP SOLUTION
The contract is for the provision of a Next Generation Sequencing (NGS) panel, associated reagents, technical support, training and related services to support diagnostic testing for Familial Hypercholesterolaemia (FH) within the All Wales …
-
Waiver - BWC_RQ3 - Nonacus Ltd - Reagents
This service relates to the Reagents by Nonacus Ltd
About
- What it does
- Research and experimental development on biotechnology
- Incorporated
- 14/05/2015
- Registered office
- Birmingham
Ownership
Owned by (4) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Christopher David Sale ceased 2023-06-27
25-50% shares, 25-50% voting · notified 2016-04-06 - confirmed: also a director of this company - Lee Daniel Silcock ceased 2023-06-27
25-50% shares, 25-50% voting · notified 2016-04-06 - Graham Robert Snudden ceased 2023-06-27
significant influence · notified 2016-04-06 - Advanced Genomics Limited
75-100% shares, 75-100% voting, appoints directors · notified 2023-06-27
Group
- Nonacus Limited
is controlled by Christopher David Sale
Evidence
ceased 25-50% shares, 25-50% voting · notified 2016-04-06, ceased 2023-06-27 · source: Companies House PSC register
Ultimately controlled by Christopher David Sale.
2 other companies in this group
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Grants received
1 grant · £49,591 total360Giving data, published by funders. Coverage only includes funders who publish their grants to 360Giving, so these figures are a floor, not a complete picture.
Top funders
- Department for Business, Energy and Industrial Strategy · £49,591
Most recent
- Department for Business, Energy and Industrial Strategy
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
4 directors on the board
- Graham Robert Snudden Director · appointed 2016
- Jeffrey Bousfield Director · appointed 2026
- Lee Daniel Silcock Director · appointed 2015
- Christopher David Sale Director · appointed 2015
Directors past 6 years
- Graham Robert Snudden Director · appointed 2016
- Lee Daniel Silcock Director · appointed 2015
- Christopher David Sale Director · appointed 2015
First-time vs portfolio directors
Portfolio (4)
- Graham Robert Snudden Director · appointed 2016
- Jeffrey Bousfield Director · appointed 2026
- Lee Daniel Silcock Director · appointed 2015
- Christopher David Sale Director · appointed 2015
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Gaps to watch
- Several long-serving directors could step down together
- Narrow spread of sectors across the board
Where to look Suggested search: succession planning for long-tenured seats; directors from a wider range of sectors.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 09590278
- Status
- Active
- Type
- Private Limited Company
- Accounts next due
- 30/09/2027
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data